Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: A Tennessee Medicaid study

BMC Medical Research Methodology

Volumn 12, Issue , 2012, Pages

  Bobo, William V ^a   Cooper, William O ^a   Stein, C Michael ^a   Olfson, Mark ^b   Mounsey, Jackie ^a   Daugherty, James ^a   Ray, Wayne A ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c Veterans Administration Tennessee Valley Health Care System   (United States)

Author keywords

Computer case definition; Health administrative data; Positive predictive value; Type 2 diabetes; Validity

Indexed keywords

ANTIDIABETIC AGENT; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; DATA BASE; DIABETES MELLITUS; ELECTRONIC PRESCRIBING; FEMALE; HUMAN; MALE; MEDICAID; REPRODUCIBILITY; STANDARD; UNITED STATES;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; DATABASES AS TOPIC; DIABETES MELLITUS; ELECTRONIC PRESCRIBING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICAID; REPRODUCIBILITY OF RESULTS; TENNESSEE; UNITED STATES; YOUNG ADULT;

EID: 84865280779     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-12-128     Document Type: Review

References (37)

1. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM, J Pediatr 2000 136 5 664 672 10.1067/mpd.2000. 105141 10802501 (Pubitemid 30318399)
2. The global spread of type 2 diabetes mellitus in children and adolescents. Pinhas-Hamiel O, Zeitler P, J Pediatr 2005 146 5 693 700 10.1016/j.jpeds.2004.12.042 15870677 (Pubitemid 40616257)
3. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. Nat Genet 2010 42 7 579 589 10.1038/ng.609 20581827
4. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Herder C, Roden M, Eur J Clin Invest 2011 41 6 679 692 10.1111/j.1365-2362.2010. 02454.x 21198561
5. Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Nettleton JA, McKeown NM, Kanoni S, Lamaitre RN, Hivert MF, et al. Diabetes Care 2010 33 12 2684 2691 10.2337/dc10-1150 20693352
6. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC, N Engl J Med 2001 345 11 790 797 10.1056/NEJMoa010492 11556298
7. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Benditti E, Nathan DM, Lancet 2009 374 9702 1677 1686 10.1016/S0140-6736(09)61457-4 19878986
8. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Kjunti K, BMJ 2007 334 7588 299 10.1136/bmj.39063.689375.55 17237299 (Pubitemid 46293963)
9. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Hectors TL, Vanparys C, van der Ven K, Martens GA, Jorens PG, van Gaal LF, Covaci A, De Coen W, Blust R, Diabetologia 2011 54 6 1273 1290 10.1007/s00125-011-2109-5 21442161
10. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. Newcomer JW, CNS Drugs 2005 19 Suppl 1 1 93 15998156 (Pubitemid 40677047)
11. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. McIntyre RS, Jerrell JM, Arch Pediatr Adolesc Med 2008 162 10 929 935 10.1001/archpedi.162.10.929 18838645
12. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Correll CU, Carlson HE, J Am Acad Child Adolesc Psychiatry 2006 45 7 771 791 10.1097/01.chi.0000220851.94392.30 16832314 (Pubitemid 43932904)
13. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Beckman JA, Creager MA, Libby P, JAMA 2002 287 19 2570 2581 10.1001/jama.287.19.2570 12020339 (Pubitemid 34517204)
14. Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Bowden DW, Cox AJ, Freedman BI, Hugenschimdt CE, Wagenknecht LE, Herrington D, Agarwal S, Register TD, Maldjian JA, Ng MC, Hsu FC, Langefeld CD, Williamson JD, Carr JJ, Rev Diabet Stud 2010 7 3 188 201 21409311
15. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Pinhas-Hamiel O, Zeitler P, Lancet 2007 369 9575 1823 1831 10.1016/S0140-6736(07)60821-6 17531891 (Pubitemid 46783022)
16. Population-based studies of adverse drug effects. Ray WA, N Engl J Med 2003 349 17 1592 1594 10.1056/NEJMp038145 14573730 (Pubitemid 37288566)
17. Improving automated database studies. Ray WA, Epidemiology 2011 22 3 302 304 10.1097/EDE.0b013e31820f31e1 21464650
18. Use of Medicaid data for pharmacoepidemiology. Ray WA, Griffin MR, Am J Epidemiol 1989 129 4 837 849 2646920 (Pubitemid 19094261)
19. The use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). Geller DH, Pacaud D, Gordon CM, Misra M, Int J Pediatr Endocrinol 2011 11 9
20. Standards of medical care in diabetes - 2011. American Diabetes Association, Diabetes Care 2011 34 Suppl 1 11 S61 21193625
21. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 62 S69 20042775
22. Haynes RB, Sackett DL, Guyatt GH, Tigwell P, Clinical Epidemiology New York: Lippincott Williams & Wilkins 3 2006
23. Diabetes in Navajo youth. Dabelea D, DeGroat J, Sorrelman C, Glass M, Percy CA, Avery C, Hu D, DAgostino RB, Beyer J, Imperatore G, Testaverde L, Klingensmith G, Hamman RF, Diabetes Care 2009 32 Suppl 2 141 S137 19246579
24. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Unwin N, Shaw J, Zimmet P, Alberti KG, Diabet Med 2002 19 9 708 723 12207806 (Pubitemid 35013848)
25. Epidemiology of prediabetes. Colagiuri S, Med Clin North Am 2011 95 2 299 307 10.1016/j.mcna.2010.11.003 21281834
26. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Coccurello R, Moles A, Pharmacol Ther 2010 127 3 210 251 10.1016/j.pharmthera.2010.04.008 20493213
27. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K, Am J Epidemiol 2006 164 7 672 681 10.1093/aje/kwj289 16943266 (Pubitemid 44453496)
28. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S, JAMA 2011 305 24 2525 2531 10.1001/jama.2011.878 21693740
29. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Miller DR, Safford MM, Pogach LM, Diabetes Care 2004 27 Suppl 2 10 B21 15113777
30. Type 2 diabetes in the young: the evolving epidemic. Bloomgarden ZT, Diabetes Care 2004 27 4 998 1010 10.2337/diacare.27.4.998 15047665 (Pubitemid 38420231)
31. ISPAD Clinical Practice Consensus Guidelines 2006-2007: Type 2 diabetes mellitus in the child and adolescent. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ, Pediatric Diabetes 2008 9 5 512 526 10.1111/j.1399-5448.2008.00429.x 18694453
32. Validation of a pediatric diabetes case definition using administrative health data in Manitoba, Canada. Dart A, Martens PJ, Sellers EA, Brownell MD, Rigatto C, Dean HJ, Diabetes Care 2011 34 4 898 903 10.2337/dc10-1572 21378211
33. Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Rhodes ET, Laffel LM, Gonzalez TV, Ludwig DS, Diabetes Care 2007 30 1 141 143 10.2337/dc06-1142 17192348 (Pubitemid 46052513)
34. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC, Br J Clin Pharmacol 2009 67 2 242 249 10.1111/j.1365-2125.2008.03347.x 19260863
35. Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations. Rosenbloom AL, Paediatric Drugs 2002 4 4 209 221 11960510 (Pubitemid 34494026)
36. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Li H, Isomaa B, Taskinen MR, Groop L, Tuomi T, Diabetes Care 2000 23 5 589 594 10.2337/diacare.23.5.589 10834414 (Pubitemid 30321535)
37. Piedmont Study Group for Diabetes Epidemiology: Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S, Novelli G, Trovati M, Cerutti F, Pagano G, Diabetes Care 2005 28 11 2613 2619 10.2337/diacare.28.11.2613 16249528 (Pubitemid 43951148)